Literature DB >> 22564170

Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids.

Vatsal Shah1, Oleh Taratula, Olga B Garbuzenko, Mahesh L Patil, Ronak Savla, Min Zhang, Tamara Minko.   

Abstract

The prevention of cyto- and genotoxicity of nanocarriers is an important task in nanomedicine. In the present investigation, we, at the first time using similar experimental conditions, compared genotoxicity of nanocarriers with different composition, architecture, size, molecular weight and charge. Poly(ethylene glycol) polymers, neutral and cationic liposomes, micelles, poly(amindo amine) and poly(propyleneimine) dendrimers, quantum dots, mesoporous silica, and supermagnetic iron oxide (SPIO) nanoparticles were studied. All nanoparticles were used in non-cytotoxic concentrations. However, even in these concentrations, positively charged cationic liposomes, dendrimers, and SPIO nanoparticles induced genotoxicity leading to the significant formation of micronuclei in cells. Negatively charged and neutral nanocarriers were not genotoxic. A strong positive correlation was found between the number of formed micronuclei and the positive charge of nanocarriers. We proposed modifications of both types of dendrimers and SPIO nanoparticles that substantially decreased their genotoxicity and allowed for an efficient intracellular delivery of nucleic acids.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22564170      PMCID: PMC3899095     

Source DB:  PubMed          Journal:  Curr Drug Discov Technol        ISSN: 1570-1638


  30 in total

Review 1.  Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.

Authors:  David B Warheit; E Maria Donner
Journal:  Nanotoxicology       Date:  2010-12       Impact factor: 5.913

Review 2.  Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes.

Authors:  Oleh Taratula; Olga Garbuzenko; Ronak Savla; Y Andrew Wang; Huixin He; Tamara Minko
Journal:  Curr Drug Deliv       Date:  2011-01       Impact factor: 2.565

3.  Safety assessment of nanoparticles cytotoxicity and genotoxicity of metal nanoparticles in vitro.

Authors:  Magdolenova Zuzana; Rinna Alessandra; Fjellsbø Lise; Dusinska Maria
Journal:  J Biomed Nanotechnol       Date:  2011-02       Impact factor: 4.099

4.  Genotoxic potential evaluation of a cosmetic insoluble substance by the micronuclei assay.

Authors:  N Dayan; V Shah; T Minko
Journal:  J Cosmet Sci       Date:  2011 Jan-Feb       Impact factor: 0.948

5.  Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer.

Authors:  Ronak Savla; Oleh Taratula; Olga Garbuzenko; Tamara Minko
Journal:  J Control Release       Date:  2011-02-20       Impact factor: 9.776

6.  LHRH-targeted nanoparticles for cancer therapeutics.

Authors:  Tamara Minko; Mahesh L Patil; Min Zhang; Jayant J Khandare; Maha Saad; Pooja Chandna; Oleh Taratula
Journal:  Methods Mol Biol       Date:  2010

7.  Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles.

Authors:  Atul Asati; Santimukul Santra; Charalambos Kaittanis; J Manuel Perez
Journal:  ACS Nano       Date:  2010-09-28       Impact factor: 15.881

8.  Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.

Authors:  Alex M Chen; Min Zhang; Dongguang Wei; Dirk Stueber; Oleh Taratula; Tamara Minko; Huixin He
Journal:  Small       Date:  2009-12       Impact factor: 13.281

Review 9.  Clinical toxicities of nanocarrier systems.

Authors:  Karina R Vega-Villa; Jody K Takemoto; Jaime A Yáñez; Connie M Remsberg; M Laird Forrest; Neal M Davies
Journal:  Adv Drug Deliv Rev       Date:  2008-02-07       Impact factor: 15.470

10.  Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition.

Authors:  Hui Yang; Chao Liu; Danfeng Yang; Huashan Zhang; Zhuge Xi
Journal:  J Appl Toxicol       Date:  2009-01       Impact factor: 3.446

View more
  22 in total

1.  In vitro toxicity evaluation of silica-coated iron oxide nanoparticles in human SHSY5Y neuronal cells.

Authors:  Gözde Kiliç; Carla Costa; Natalia Fernández-Bertólez; Eduardo Pásaro; João Paulo Teixeira; Blanca Laffon; Vanessa Valdiglesias
Journal:  Toxicol Res (Camb)       Date:  2015-10-23       Impact factor: 3.524

2.  Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human retinal pigment epithelial cells.

Authors:  Panagiotis Mastorakos; Siva P Kambhampati; Manoj K Mishra; Tony Wu; Eric Song; Justin Hanes; Rangaramanujam M Kannan
Journal:  Nanoscale       Date:  2015-03-07       Impact factor: 7.790

Review 3.  Bioengineering a non-genotoxic vector for genetic modification of mesenchymal stem cells.

Authors:  Xuguang Chen; Alireza Nomani; Niket Patel; Faranak S Nouri; Arash Hatefi
Journal:  Biomaterials       Date:  2017-10-20       Impact factor: 12.479

4.  MXD3 antisense oligonucleotide with superparamagnetic iron oxide nanoparticles: A new targeted approach for neuroblastoma.

Authors:  Sakiko Yoshida; Connie Duong; Michael Oestergaard; Michael Fazio; Cathy Chen; Rachael Peralta; Shuling Guo; Punit P Seth; Yueju Li; Laurel Beckett; Nitin Nitin; Noriko Satake
Journal:  Nanomedicine       Date:  2019-11-26       Impact factor: 5.307

5.  Targeted nanomedicine for suppression of CD44 and simultaneous cell death induction in ovarian cancer: an optimal delivery of siRNA and anticancer drug.

Authors:  Vatsal Shah; Oleh Taratula; Olga B Garbuzenko; Olena R Taratula; Lorna Rodriguez-Rodriguez; Tamara Minko
Journal:  Clin Cancer Res       Date:  2013-09-13       Impact factor: 12.531

6.  Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia.

Authors:  Noriko Satake; Connie Duong; Cathy Chen; Gustavo A Barisone; Elva Diaz; Joseph Tuscano; David M Rocke; Jan Nolta; Nitin Nitin
Journal:  Br J Haematol       Date:  2014-09-08       Impact factor: 6.998

7.  Delivery of antisense oligonucleotides using poly(alkylene oxide)-poly(propylacrylic acid) graft copolymers in conjunction with cationic liposomes.

Authors:  Lavanya Y Peddada; Olga B Garbuzenko; David I Devore; Tamara Minko; Charles M Roth
Journal:  J Control Release       Date:  2014-09-01       Impact factor: 9.776

8.  Molecular Inclusion Complexes of β-Cyclodextrin Derivatives Enhance Aqueous Solubility and Cellular Internalization of Paclitaxel: Preformulation and In vitro Assessments.

Authors:  Milin Shah; Vatsal Shah; Anasuya Ghosh; Zheng Zhang; Tamara Minko
Journal:  J Pharm Pharmacol (Los Angel)       Date:  2015-01-10

9.  A Triple Role for a Bilayer: Using Nanoliposomes to Cross and Protect Cellular Membranes.

Authors:  Daniel E Otzen; Dina Morshedi; Hossein Mohammad-Beigi; Farhang Aliakbari
Journal:  J Membr Biol       Date:  2021-01-11       Impact factor: 1.843

Review 10.  Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs).

Authors:  Weina Ke; Kirill A Afonin
Journal:  Adv Drug Deliv Rev       Date:  2021-06-16       Impact factor: 17.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.